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Background: This study aims to explore the correlation between expression of differentiated embryo-chondrocyte
expressed gene l (DEC1) and oral squamous cell carcinoma (OSCC), which could provide the reference for treatment
and prognosis assessment of OSCC.
Methods: The expression of DEC1 in tissues from 56 primary OSCC patients and 20 normal oral mucosa samples
were detected using real-time polymerase chain reaction and immunohistochemical methods, respectively.
Results: The results showed that the positive expression rate of DEC1 in the OSCC group was significantly higher
than that in the normal group (P <0.05); further, the expression of DEC1 in different OSCC groups was statistically
significant (P <0.05). The expression of DEC1 in the 1-year recurrence OSCC group was significantly higher than
other groups. The expression of DEC1 in the 3-years no recurrence OSCC group was the lowest.
Conclusions: The expression of DEC1 was associated with the incidence of OSCC and there was a negative
correlation between the expression of DEC1 and the prognosis of OSCC.
Keywords: Differentiated embryo-chondrocyte expressed gene l, Immunohistochemistry, Metastasis, Oral squamous
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Oral squamous cell carcinoma (OSCC) is the most com-
mon malignant tumor in the oral and maxillofacial re-
gion; lymph node metastasis occurs at an early stage and
distant metastasis through the blood circulation is ad-
vanced. Despite operation plus radiotherapy, chemo-
therapy, and other comprehensive sequence therapies,
the 5-year survival rate for OSCC patients has not im-
proved significantly. In particular, recurrence or metastasis
of cervical lymph nodes and distant metastasis shortly
after surgery frequently occur. Therefore, it is imminent
to pay more attention to the study of tumor recurrence
and metastasis genes for OSCC.
A previous study [1] has confirmed the over-expression
of the differentiated embryo-chondrocyte expressed gene l
(DEC1) gene in OSCCs. This study will focus on the* Correspondence: tongsus@163.com
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unless otherwise stated.correlation between prognosis of OSCC and expression
of DEC1, which could provide guidance for evaluating
prognosis and improve the treatment of OSCC.Methods
Ethical statement
Any experimental research that is reported in the manu-
script has been performed with the approval of the Research
Ethics Committee of Xiangya Hospital of Central South
University. Research carried out on humans was in com-
pliance with the Helsinki Declaration.Patients and specimen collection
A total of 56 patients (39 male, 17 female; age, 37–62 years
old) who were diagnosed with OSCC (high differentiation,
grade III to IV, preoperative without radiotherapy and
chemotherapy) by pathological diagnosis in the Department
of Oral and Maxillofacial Surgery of Xiangya Hospital of
Central South University from January 2008 to October
2012, were recruited. The tumor samples were divided. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Comparison results of expression of DEC1 gene
in different groups
Group n DEC1 t P
Ca (2-ΔΔCt value) Nm (2-ΔΔCt value)
1 14 9.73 ± 2.09 1.02 ± 0.18 11.731 0.000
2 14 6.64 ± 0.92a 1.05 ± 0.15 16.962 0.000
3 14 5.47 ± 1.15a 0.98 ± 0.14 11.226 0.000
4 14 4.31 ± 0.85ab 0.94 ± 0.21 10.925 0.000
Group 1: 1-year recurrence OSCC group; Group 2: 1- to 2-year recurrence OSCC
group; Group 3: 2- to 3-year recurrence OSCC group; Group 4: 3 years without
recurrence OSCC group.
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frozen in liquid nitrogen and stored at −80°C; the
remaining samples were embedded in paraffin for im-
munohistochemistry (IHC). According to the criteria
of UICC TNM staging classification system for oral
and maxillofacial tumor in 2002 [2], they were all high
differentiated carcinoma. TNM stage: 35 cases in stage
III, 21 cases in stage IV; 51 cases had lymph node me-
tastasis; 42 cases had tissue metastasis and recurrence
within 3 years (14 cases had tissue metastasis and re-
currence within 1 year, 14 cases had tissue metastasis
and recurrence in within 1 to 2 years, and 14 cases had
tissue metastasis and recurrence within 2 to 3 years),
14 cases had no tissue metastasis or recurrence in
3 years. At the same time, 20 cases of normal oral mucosa
were randomly divided into 4 groups as a control.
Real-time quantitative polymerase chain reaction
The total RNA was extracted with the TRIzol method.
They were performed according to the manual of tissue
RNA extraction TRIzol Reagent kit (Invitrogen, CA, USA).
Briefly, 2 μg total RNA was taken from each sample to
reverse transcription to cDNA according to the manual
of RevertAid First StrandcDNA Synthesis Kit (Thermo
Scientific, Pittsburgh, PA, USA), and then PCR was
performed with SYBR® Premix Ex Taq kit (TaKaRa
Biotechnology Co., Ltd, Dalian, China). The primers for
DEC1 were as follows: F: 5'-TTTTACTGATGCCCTGC
ACA-3'; R: 5'-CAATCTGCAATTCCCTCTGC-3'. The
primers for β-actin, which was used as an internal reference,
were as follows: F: 5'-GGCATGGGTCAGAAGGATT-3'; R:
5'-TGGTGCCAGATTTTCTCCA-3'. Reaction conditions
were as follows: 95°C for 30 s, 1 cycle; 95°C for 5 s and
60°C for 30 s, 40 cycles. The 2–ΔΔCt method [3] was used
to calculate the expression of DEC1 gene in OSCC tissues
and normal oral mucosa tissues.
Immunohistochemistry detection
Pathological paraffin blocks were cut into 4 μm continu-
ous sections for IHC staining. Following deparaffinization,
dehydration, and antigen retrieval, the sections were incu-
bated with 1:200 diluted DEC1 rat monoclonal antibody
against human at 4°C overnight. After that, they were
washed with PBS and incubated at 37°C in a water bath
for 2 h after drop-adding the second antibody and washing
with PBS. After treatment with the DAB solution, they were
flushed completely, counterstained with hematoxylin,
washed with water, treated with dehydration and trans-
parency media, mounted on slides, and observed under
the microscope. The IHC staining results were scored
by the pathologist and author separately so as to minimize
the subjective factors, compared, and the final compre-
hensive results were obtained. The results were expressed
as the staining index score which was calculated as theproduct of A and B. A was the categorical score of the
proportion of positively stained cells in five random
microscopic fields: positive cells ≤5% = 0; 6% to 25%
positive cells = l; 26% to 50% positive cells = 2; 51% to 75%
positive cells = 3; and positive cells >75% = 4. B was the cat-
egorical score of the staining intensity: 0 = no positive stain-
ing; 1 = light yellow staining; 2 = pale brown staining; 3 =
bright brown staining. Each section was observed under
the × 400 microscope, for 5 continuous high power fields
and 100 cells were observed, taking their mean value. Inte-
gration optic density (IOD) values of positive staining
screenshots taken by Leica DM5000B micrograph analysis
system (Leica DMI5000B, Germany) and calculated using
the Image Pro Plus 6.0 Image analysis software. IOD values
and positive expression intensity were positively correlated.
Statistical analysis
All statistical analysis was done using SPSS 18.0 for
windows (SPSS, Inc., Chicago, IL, USA). A student two-
tailed non-paired t-test was used to determine significant
differences between treatment and control. P <0.05 was
considered as statistically significant.
Results
Analysis of DEC1 mRNA expression in different prognostic
groups of OSCC tissue and normal mucosa tissue
The expression of DEC1 mRNA in different prognosis
OSCC groups was significantly higher than that of the
normal group; the difference was statistically significant
(P <0.05, Table 1). The expression of DEC1 mRNA in the
1-year recurrence OSCC group was significantly higher
than in the other groups (P <0.05). The 3 years without
recurrence OSCC group had the lowest expression of
DEC1 mRNA among them. The expression of DEC1
mRNA in the normal group was significantly lower
than that in the OSCC group (P <0.05, Table 1).
Expression of DEC1 protein in different prognosis of OSCC
IHC staining results are shown in Figure 1. The staining
index score of OSCC tissues was higher than that of
normal mucosa tissues, so the expression level of DEC1 in
the OSCC group was significantly higher than that of the
Figure 1 Expression of DEC1 protein in human normal oral mucosa tissue and OSCC tissue (SP × 400). (A) Normal oral mucosa tissue
(negative), (B) OSCC tissue (positive).
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in different groups are shown in Figure 2. IOD values of
DEC1 expression in the 1-year recurrence OSCC group
was significantly higher than that of other groups. The
3-year without recurrence group had the lowest IOD
value (P <0.05).
Discussion
The DEC1 is a member of the basic helix loop protein
family containing the basic helix loop (b HLH) structure.
It plays an important role in cartilage formation, growth
of axons, biological clock regulation, cell differentiation,
and tumor development. The human DEC1 gene is lo-
cated at p25.3-26 on chromosome 3. Its size is about
5.7 Kb, including 5 exons and 4 introns [4]. There are
many transcription factor binding sites, including CAMP
and E-box response element, at its 5'-end [5]. DEC1 protein
is composed of 412 amino acids and plays a physiologicalFigure 2 IOD values of DEC1 in different prognostic OSCC groups. Gr
OSCC group; Group 3: 2 to 3 years recurrence OSCC group; Group 4: 3 yearegulating role through the activation of the phosphor-
ylation sites. DEC1 protein is widely expressed in liver,
intestine, and cartilage tissues. Studies have found it to
be overexpressed in various tumors, including leukemia
[6], lung cancer [7], liver cancer [8], renal cell carcinoma
[9], gastric cancer [10], and pancreatic cancer [11]. How-
ever, to date, there has been no reports regarding the
expression of DEC1 in OSCC.
According to previous studies on DEC1 expression
and hypoxia-inducible factor 1 alpha (HIF-1α), a high ex-
pression of DEC1 in tumor tissue was induced by hypoxia
[9,10]. In the hypoxic environment of tumor cells, the
expression of DEC1 was up-regulated, which could in-
hibit the expression of cellular apoptosis-related fac-
tors, such as HIF-1α and p53, and promote the growth
of tumor cells. The studies have shown that hypoxia
can induce the expression of DEC1 in gastric cancer
and pancreatic cancer cell lines [9,10]. Zheng et al. [10]oup 1: 1-year recurrence OSCC group; Group 2: 1 to 2 years recurrence
rs without recurrence OSCC group.
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and the expression of DEC1 was higher than that of
HIF-1α in a normal environment. Hypoxia could induce
the expression of DEC1 mRNA but had no significant ef-
fect on the expression of HIF-1α mRNA. The expression
of DEC1 mRNA was significantly reduced when inhibiting
the expression of HIF-1α.
The tight junction protein 1 (claudin-1) is an important
inhibition protein of tumor infiltration function. Liu et al.
[12] studied the correlation between expression of
claudin-1, DEC1, and invasion of breast cancer. They
found that the expression of DEC1 is positively correlated
with grade of breast cancer and negatively correlated
with the expression of claudin-1. Further experiments
found that the expression of claudin-1 mRNA and pro-
tein level were enhanced and reduced cell invasive ability
after DEC1 gene silencing in breast cancer cell lines
(MCF-7 and MDA-MB-231). Therefore, overexpression
of DEC1 may be adjusted through the mechanism of
down-regulation of claudin-1 to promote the invasion
and metastasis of breast cancer.
The classic tumor suppressor p53 gene can be activated
under the conditions of hypoxia, DNA damage, and onco-
gene activation, which mediate the blocking of cell periodic
apoptosis and the aging process. A study found that DEC1
and p53 could form a feedback loop to control apoptosis
induced by DNA damage through macrophage inhibitory
cytokine 1 (MIC-1) [13]. DEC1 inhibited the combination
of MIC-1 gene promoter and p53 following DNA dam-
age and reduced the expression of MIC-1. The regulat-
ing mechanism between DEC1 and p53 may promote
the development of tumors.
Epithelial mesenchymal transition (EMT) is an important
step in the invasion and migration of tumor cells. Wu et al.
[14] studied the role of DEC1 in EMT in vitro with human
PANC-1 cells. They found that TGF-β up-regulated the
expression of DEC1 and regulated the expression of EMT
localization-related factors such as phosphorylated Smad3
(pSmad3), Claudin-4, and N-cadherin in PANC-1 cells.
In the presence of TGF-β during DEC1 gene silencing,
the EMT process was inhibited and TGF-β induced PANC-
1 cells to adopt a fusiform shape. In addition, synergistic
effects of the expression of DEC1 and TGF-β were closely
related to the invasion and migration of PANC-1 cells.
These findings suggest that DEC1 plays an important role
in promoting tumor cell invasion and metastasis by regu-
lating EMT-related factors in pancreatic cancer.
Conclusions
This experiment found that in OSCC patients (stage III
to IV), the expression of DEC1 in different prognosis
groups had a significant difference (P <0.05). The expression
of DEC1 in the 1-year recurrence group was significantly
higher than in other groups. The expression of DEC1in the 3 years without recurrence group was the lowest.
These data showed that the expression of DEC1 may
be negatively correlated to the prognosis of OSCC. The
results further defined the important role of DEC1 in
promoting tumor invasion and metastasis.
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